β-Galactosidase–responsive prodrugs of chemotherapeutics targeted to cancer surface receptors

2012 Science-Business eXchange  
doi:10.1038/scibx.2012.1064 fatcat:m5eb5nq5yrettaqw3ie4mh7bli